Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Planer, David ^a   Metzger, Shulamit ^a   Zcharia, Eyal ^a   Wexler, Isaiah D ^a   Vlodavsky, Israel ^a   Chajek Shaul, Tova ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEPARANASE; LIPOPROTEIN; LIPOPROTEIN LIPASE; PROTEOHEPARAN SULFATE; RETINOL; TRIACYLGLYCEROL; BETA GLUCURONIDASE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENOTYPE; IN VIVO STUDY; LIPID DIET; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROSCLEROTIC PLAQUE; BLOOD; C57BL MOUSE; ENZYMOLOGY; GENETICS; HUMAN; INTESTINE; LIVER; MALE; METABOLISM; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; TRANSPORT AT THE CELLULAR LEVEL;

MUS; MUS MUSCULUS;

ANIMALS; BIOLOGICAL TRANSPORT; GLUCURONIDASE; HUMANS; INTESTINES; LIPOPROTEINS; LIVER; MALE; MICE; MICE, INBRED C57BL; PLAQUE, ATHEROSCLEROTIC; POSTPRANDIAL PERIOD;

EID: 79953692987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018370     Document Type: Article

References (36)

1. Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, et al. (1990) Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 9: 203-226.
2. Williams KJ, Fuki IV, (1997) Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism. Curr Opin Lipidol 8: 253-262.
3. MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A, et al. (2007) Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117: 153-164.
4. Mahley RW, Huang Y, (2007) Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing. J Clin Invest 117: 94-98.
5. Williams KJ, (2008) Molecular processes that handle - and mishandle - dietary lipids. J Clin Invest 118: 3247-3259.
6. Toyoshima M, Nakajima M, (1999) Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem 274: 24153-24160.
7. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, et al. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5: 793-802.
8. Ji ZS, Sanan DA, Mahley RW, (1995) Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J Lipid Res 36: 583-592.
9. Ebara T, Conde K, Kako Y, Liu Y, Xu Y, et al. (2000) Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J Clin Invest 105: 1807-1818.
10. Stanford KI, Bishop JR, Foley EM, Gonzales JC, Niesman IR, et al. (2009) Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. J Clin Invest.
11. Zcharia E, Metzger S, Chajek-Shaul T, Aingorn H, Elkin M, et al. (2004) Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. Faseb J 18: 252-263.
12. George J, Afek A, Shaish A, Levkovitz H, Bloom N, et al. (2001) 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 104: 1646-1650.
13. Metzger S, Hassin T, Barash V, Pappo O, Chajek-Shaul T, (2001) Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. Am J Physiol Endocrinol Metab 281: E957-965.
14. Goldberg DM, Chajek-Shaul T, (1990) Effect of chronic heparin administration on serum lipolytic activity and some aspects of lipid metabolism. Biochim Biophys Acta 1047: 103-111.
15. Ishibashi S, Perrey S, Chen Z, Osuga J, Shimada M, et al. (1996) Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271: 22422-22427.
16. Chang S, Zhang SH, Maeda N, Borensztajn J, (1994) Hepatic clearance of chylomicron remnants in mice lacking apoprotein E. Biochim Biophys Acta 1215: 205-208.
17. Williams KJ, Liu ML, Zhu Y, Xu X, Davidson WR, et al. (2005) Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II. Diabetes 54: 1116-1122.
18. Williams KJ, Chen K, Recent insights into factors affecting remnant lipoprotein uptake. Curr Opin Lipidol 21: 218-228.
19. Fuki IV, Iozzo RV, Williams KJ, (2000) Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism. J Biol Chem 275: 25742-25750.
20. Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP, et al. (1997) The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J Clin Invest 100: 1611-1622.
21. Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, et al. (2005) In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Proc Natl Acad Sci U S A 102: 6473-6477.
22. Zheng C, Murdoch SJ, Brunzell JD, Sacks FM, (2006) Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans. Arterioscler Thromb Vasc Biol 26: 891-896.
23. Weinstein MM, Yin L, Tu Y, Wang X, Wu X, et al. Chylomicronemia elicits atherosclerosis in mice-brief report. Arterioscler Thromb Vasc Biol 30: 20-23.
24. Zhang X, Qi R, Xian X, Yang F, Blackstein M, et al. (2008) Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res 102: 250-256.
25. Beigneux AP, Davies BS, Gin P, Weinstein MM, Farber E, et al. (2007) Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab 5: 279-291.
26. Franssen R, Young SG, Peelman F, Hertecant J, Sierts JA, et al. (2010) Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet 3: 169-178.
27. Zilversmit DB, (1979) Atherogenesis: a postprandial phenomenon. Circulation 60: 473-485.
28. Boquist S, Ruotolo G, Tang R, Bjorkegren J, Bond MG, et al. (1999) Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation 100: 723-728.
29. Noto AT, Mathiesen EB, Brox J, Bjorkegren J, Hansen JB, (2008) Delayed metabolism of postprandial triglyceride-rich lipoproteins in subjects with echolucent carotid plaques. Lipids 43: 353-360.
30. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, et al. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 12: 1336-1345.
31. Mero N, Malmstrom R, Steiner G, Taskinen MR, Syvanne M, (2000) Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 150: 167-177.
32. Tabas I, Williams KJ, Boren J, (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116: 1832-1844.
33. Chung BH, Tallis G, Yalamoori V, Anantharamaiah GM, Segrest JP, (1994) Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscler Thromb 14: 622-635.
34. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, et al. (1994) Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 14: 1767-1774.
35. Kudchadkar R, Gonzalez R, Lewis KD, (2008) PI-88: a novel inhibitor of angiogenesis. Expert Opin Investig Drugs 17: 1769-1776.
36. Vlodavsky I, Ilan N, Naggi A, Casu B, (2007) Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13: 2057-2073.